Intellia Therapeutics Stock Momentum Indicators Average Directional Movement Index

Key Indicators . Data . Stocks . USA . 
Stock . Intellia Therapeutics
NTLA Stock  USD 13.73  0.00  0.00%   
This analysis presents Average Directional Movement Index indicator for Intellia Therapeutics, which tracks the rate and magnitude of price change in Intellia Therapeutics, measuring whether buying or selling pressure is accelerating or fading. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function.The average directional index (ADX) measures the strength of a prevailing trend of Intellia Therapeutics and whether movement exists in the market. The ADX is measured on a scale of 0 to 100. A low Intellia Therapeutics ADX value usually indicates a non-trending market with low volumes, whereas a cross above 20 may indicate the start of a trend. If the ADX is over 40 and begins to fall, it can indicate the slowdown of a current trend. This indicator can also be used to identify non-trending markets, or a deterioration of an ongoing trend. Although market direction is important in its calculation, the ADX is not a directional indicator

Intellia Therapeutics Technical Analysis Modules

A technical review of Intellia Therapeutics evaluates how price, volume, and momentum indicators converge or diverge to signal directional bias. Divergences between price action and indicator readings often precede meaningful reversals or acceleration.
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Technical Indicator Methodology & Signal Interpretation

Momentum indicators measure the rate and magnitude of price change for Intellia Therapeutics, signaling whether buying or selling pressure is accelerating. The current reading should be evaluated relative to its own recent range.

Intellia Therapeutics data is compiled from periodic company reporting and market reference feeds and standardized for comparability. Where analyst coverage exists, consensus estimates are factored in.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board

Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.